Valuation: Omnicell, Inc.

Market Cap 1.69B 1.47B 1.36B 1.26B 2.36B 161B 2.41B 16.12B 6.31B 80.02B 6.34B 6.2B 269B P/E 2026 *
45.1x
P/E 2027 * 41x
Enterprise Value 1.69B 1.47B 1.36B 1.26B 2.36B 161B 2.41B 16.12B 6.31B 80.02B 6.34B 6.2B 269B EV / Sales 2026 *
1.36x
EV / Sales 2027 * 1.3x
Free-Float
76.27%
Yield 2026 *
-
Yield 2027 * -
1 day-10.36%
1 week-6.90%
Current month-10.62%
1 month-10.62%
3 months-10.41%
6 months-23.48%
Current year-18.08%
1 week 35
Extreme 35
44.27
1 month 35
Extreme 35
48.06
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
66.65
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
15/7/26 Sell

Chief Executive Officer

-10,000 0.0220%
1/7/26 Free

Chairperson

12,309 0.0271%
1/4/26 Free

Chief Administrative Officer

25,132 0.0553%
Change 5-day change 1-year change 3-year change Capi.($)
-10.36%-6.90%+24.95%-41.06% 1.69B
-3.05%+12.24%-29.75%+0.05% 32.74B
+0.94%+0.05%-49.27%+135.80% 11.77B
-0.75%+4.67%-23.36%+65.01% 5.63B
+3.15%+4.96% - - 2.23B
+7.26%+1.45% - - 1.8B
+3.26%+2.03%-32.81% - 1.01B
+2.80%-1.34%+33.64%+103.23% 871M
-0.88%+1.51%-41.97%-54.47% 770M
+5.16%+1.15%+476.09%+754.84% 653M
Average +0.75%+0.40%+44.69%+137.63% 5.92B
Weighted average by Cap. -1.39%+6.21%-24.82%+45.04%

Financials

2026 *2027 *
Net sales 1.24B 1.08B 1B 923M 1.74B 118B 1.77B 11.85B 4.64B 58.81B 4.66B 4.56B 198B 1.3B 1.13B 1.05B 968M 1.82B 124B 1.86B 12.42B 4.86B 61.68B 4.88B 4.78B 207B
Net income 37.83M 32.86M 30.52M 28.14M 53.01M 3.61B 53.97M 361M 141M 1.79B 142M 139M 6.03B 42.57M 36.98M 34.34M 31.67M 59.65M 4.06B 60.73M 407M 159M 2.02B 160M 156M 6.79B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,525
Date Price Change Volume
30/07/26 US$37.11 -10.36% 2,045,703
29/07/26 US$41.40 -3.83% 1,309,511
28/07/26 US$43.05 +3.76% 753,773
27/07/26 US$41.49 +1.20% 838,423
24/07/26 US$41.00 +2.86% 567,479
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
37.11USD
Average target price
60.57USD
Spread / Average Target
+63.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock